AQP4 and neuromyelitis optica: However, the detection of AQP4 antibodies is neither efficient nor sensitive enough to provide an absolute diagnosis and prognosis of NMO, and reliance on this marker alone to distinguish between the two diseases can increase the chances of misdiagnosis.